**Core Concept**
Alkylating agents are a class of **chemotherapy drugs** that work by attaching an alkyl group to the DNA of cancer cells, thereby interfering with their replication and causing cell death. This mechanism is crucial in **cancer treatment**, as it helps to control the growth of malignant cells. Alkylating agents are used in the treatment of various types of **cancer**, including leukemia, lymphoma, and solid tumors.

**Why the Correct Answer is Right**
The correct answer includes **Chlorambucil** and **Busulfan**, which are both classified as alkylating agents. **Chlorambucil** is used to treat **chronic lymphocytic leukemia** and some types of **non-Hodgkin's lymphoma**. **Busulfan** is used in the treatment of **chronic myeloid leukemia**. These agents work by forming cross-links in DNA, which prevents DNA replication and transcription, ultimately leading to cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** Doxorubicin is an **anthracycline antibiotic**, not an alkylating agent. It works by intercalating into DNA and inhibiting the enzyme **topoisomerase II**.
**Option C:** Vinblastine is a **vinca alkaloid**, which works by inhibiting **microtubule formation** and is used in the treatment of **Hodgkin's lymphoma** and other cancers.
**Option E:** Methotrexate is an **antifolate drug**, which works by inhibiting the enzyme **dihydrofolate reductase** and is used in the treatment of various types of cancer and autoimmune diseases.

**Clinical Pearl / High-Yield Fact**
Alkylating agents are effective in treating certain types of cancer, but they can also have significant side effects, including **myelosuppression** and **gonadal toxicity**. It is essential to carefully monitor patients receiving these agents to minimize their adverse effects.

**Correct Answer:** D. Busulfan